Thrombotic microangiopathy (TMA) in a patient treated with antiviral therapy for hepatitis C.
UCL Centre for Nephrology, London, UK.
Rhys
R
Evans
Mathena
M
Pavan
Deepak
D
Suri
Mark
M
Harber
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D057049:Thrombotic Microangiopathies / Q000139:chemically induced*
D000998:Antiviral Agents; D016898:Interferon-alpha; D011480:Protease Inhibitors